Placenta growth factor expression is regulated by hydrogen peroxide in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 300, Issue 2, 2011, Pages

  Shaw, Jennifer H ^a   Xiang, Lingjin ^a   Shah, Anu ^a   Yin, Wei ^b   Lloyd, Pamela G ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b Oklahoma State University   (United States)

Author keywords

Angiogenesis; Arteriogenesis; Reactive oxygen species; Vascular endothelial growth factor

Indexed keywords

HYDROGEN PEROXIDE; PLACENTAL GROWTH FACTOR;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL LINE; CELLS, CULTURED; COLLATERAL CIRCULATION; CORONARY VESSELS; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; HYDROGEN PEROXIDE; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; PREGNANCY PROTEINS; RATS; STRESS, PHYSIOLOGICAL; UP-REGULATION;

EID: 79251549783     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00374.2010     Document Type: Article

References (38)

1. Angermayr B, Fernandez M, Mejias M, Gracia-Sancho J, Garcia- Pagan JC, Bosch J. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats. Gut 56: 560-564, 2007.
2. Bais C, Wu X, Yao J, Yang S, Crawford Y, McCutcheon K, Tan C, Kolumam G, Vernes JM, Eastham-Anderson J, Haughney P, Kowanetz M, Hagenbeek T, Kasman I, Reslan HB, Ross J, Van BN, Carano RA, Meng YJ, Hongo JA, Stephan JP, Shibuya M, Ferrara N. PlGF blockade does not inhibit angiogenesis during primary tumor growth. Cell 141: 166-177, 2010.
3. Boodhwani M, Nakai Y, Mieno S, Voisine P, Bianchi C, Araujo EG, Feng J, Michael K, Li J, Sellke FW. Hypercholesterolemia impairs the myocardial angiogenic response in a swine model of chronic ischemia: role of endostatin and oxidative stress. Ann Thorac Surg 81: 634-641, 2006.
4. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Med 7: 575-583, 2001.
5. Cheng SJ, Lee JJ, Kok SH, Chou CH, Chang HH, Chiang ML, Chen HM, Kuo MY, Chiang CP. Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer. Head Neck 32: 1363-1369, 2010.
6. Cianfarani F, Zambruno G, Brogelli L, Sera F, Lacal PM, Pesce M, Capogrossi MC, Failla CM, Napolitano M, Odorisio T. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol 169: 1167-1182, 2006.
7. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271: 17629-17634, 1996.
8. Coyle CH, Kader KN. Mechanisms of H2O2-induced oxidative stress in endothelial cells exposed to physiologic shear stress. ASAIO J 53: 17-22, 2007.
9. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
10. Frey RS, Ushio-Fukai M, Malik AB. NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal 11: 791-810, 2009.
11. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res 95: 449-458, 2004. (Pubitemid 39180925)
12. Koh PO, Sung JH, Won CK, Cho JH, Moon JG, Park OS, Kim MO. Streptozotocin-induced diabetes decreases placenta growth factor (PlGF) levels in rat placenta. J Vet Med Sci 69: 877-880, 2007.
13. Leung FP, Yung LM, Laher I, Yao X, Chen ZY, Huang Y. Exercise, vascular wall and cardiovascular diseases: an update (Part 1). Sports Med 38: 1009-1024, 2008.
14. Lloyd PG, Yang HT, Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ Physiol 281: H2528-H2538, 2001.
15. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nature Med 8: 831-840, 2002.
16. Maglione D, Guerriero V, Viglietto G, li-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271, 1991.
17. Mohammed KA, Nasreen N, Tepper RS, Antony VB. Cyclical stretch induces PlGF expression in bronchial epithelial cells via nitric oxide release. Am J Physiol Lung Cell Mol Physiol 292: L559-L566, 2007.
18. Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, Failla CM, Zambruno G. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 115: 2559-2567, 2002.
19. Osanai T, Fujita N, Fujiwara N, Nakano T, Takahashi K, Guan W, Okumura K. Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol Heart Circ Physiol 278: H233-H238, 2000.
20. Palmer RM, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endotheliumdependent relaxation. Biochem Biophys Res Commun 153: 1251-1256, 1988.
21. Pan P, Fu H, Zhang L, Huang H, Luo F, Wu W, Guo Y, Liu X. Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells. BMC Cell Biol 11: 36, 2010.
22. Perelman N, Selvaraj SK, Batra S, Luck LR, Erdreich-Epstein A, Coates TD, Kalra VK, Malik P. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood 102: 1506-1514, 2003.
23. Pilarczyk K, Sattler KJ, Galili O, Versari D, Olson ML, Meyer FB, Zhu XY, Lerman LO, Lerman A. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 196: 333-340, 2008.
24. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T, Martin S, van den Heuvel J, Weich H, Fernandez B, Golomb G, Carmeliet P, Schaper W, Clauss M. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 92: 378-385, 2003.
25. Pompeo E, Albonici L, Doldo E, Orlandi A, Manzari V, Modesti A, Mineo TC. Placenta growth factor expression has prognostic value in malignant pleural mesothelioma. Ann Thorac Surg 88: 426-431, 2009.
26. Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88: 1243-1276, 2008.
27. Prior BM, Lloyd PG, Ren J, Li H, Yang HT, Laughlin MH, Terjung RL. Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am J Physiol Heart Circ Physiol 287: H2434-H2447, 2004.
28. Ribatti D. The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis 11: 215-221, 2008.
29. Rocic P, Kolz C, Reed R, Potter B, Chilian WM. Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. Am J Physiol Heart Circ Physiol 292: H2729-H2736, 2007.
30. Scholz D, Elsaesser H, Sauer A, Friedrich C, Luttun A, Carmeliet P, Schaper W. Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF)-/- mice. J Mol Cell Cardiol 35: 177-184, 2003.
31. Tian J, Hou Y, Lu Q, Wiseman DA, Vasconcelos FF, Elms S, Fulton DJ, Black SM. A novel role for caveolin-1 in regulating endothelial nitric oxide synthase activation in response to H(2)O(2) and shear stress. Free Radic Biol Med 49: 159-170, 2010.
32. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111: 2347-2355, 2005. (Pubitemid 40647071)
33. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264: 85-97, 2004.
34. Van de Viere S, Stalmans I, Heindryckx F, Oura H, Tijeras-Raballand A, Schmidt T, Loges S, Albrecht I, Jonckx B, Vinckier S, Van SC, Tugues S, Rolny C, De MM, Dettori D, Hainaud P, Coenegrachts L, Contreres JO, Van BT, Cuervo H, Xiao WH, Le HC, Buysschaert I, Kharabi MB, Geerts A, Schomber T, Bonnin P, Lambert V, Haustraete J, Zacchigna S, Rakic JM, Jimenez W, Noel A, Giacca M, Colle I, Foidart JM, Tobelem G, Morales-Ruiz M, Vilar J, Maxwell P, Vinores SA, Carmeliet G, Dewerchin M, Claesson-Welsh L, Dupuy E, Van VH, Christofori G, Mazzone M, Detmar M, Collen D, Carmeliet P. Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141: 178-190, 2010.
35. Verhaeghe C, Tabruyn SP, Oury C, Bours V, Griffioen AW. Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 356: 745-749, 2007.
36. Xu HX, Zhu XD, Zhuang PY, Zhang JB, Zhang W, Kong LQ, Wang WQ, Liang Y, Wu WZ, Wang L, Fan J, Tang ZY, Sun HC. Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue. Int J Cancer 2010. June 2, (Epub ahead of print).
37. Yin W, Rubenstein DA. Dose effect of shear stress on platelet complement activation in a cone and plate shearing device. Cell Mol Bioeng 2: 274-280, 2009.
38. Yoo SA, Yoon HJ, Kim HS, Chae CB, De FS, Cho CS, Kim WU. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum 60: 345-354, 2009.